Bomanji J, Hungerford J L, Granowska M, Britton K E
Department of Nuclear Medicine, St Bartholomew's Hospital, London.
Br J Ophthalmol. 1987 Sep;71(9):651-8. doi: 10.1136/bjo.71.9.651.
The possibility of using radiolabelled monoclonal antibody fragments to image uveal melanomas has been assessed in a pilot study. 99mTc labelled F(ab')2 fragments of MoAb 225.28S raised against cutaneous melanomas were used. Initially 10 patients were imaged. In five patients the clinical findings were typical of uveal melanoma. Immunoscintigraphy was positive in all five cases. In a further five patients there was doubt about the diagnosis. One was though to have a choroidal haemangioma but failed to respond to treatment and immunoscintigraphy was positive, suggesting a diagnosis of melanoma. Two patients were assigned a diagnosis of choroidal haemangioma, one of melanocytoma or possible retinal pigment epithelium carcinoma, and one of metastasis. Immunoscintigraphy was negative in all these four cases. In combination with established diagnostic tests immunoscintigraphy may have a part to play in differentiating uveal melanoma from other similar tumours.
一项初步研究评估了使用放射性标记单克隆抗体片段对葡萄膜黑色素瘤进行成像的可能性。使用了针对皮肤黑色素瘤产生的单克隆抗体225.28S的99mTc标记F(ab')2片段。最初对10名患者进行了成像。其中5名患者的临床表现典型为葡萄膜黑色素瘤。免疫闪烁显像在所有5例中均为阳性。另外5名患者的诊断存在疑问。1例被认为患有脉络膜血管瘤,但对治疗无反应且免疫闪烁显像呈阳性,提示为黑色素瘤诊断。2例患者被诊断为脉络膜血管瘤,1例为黑素细胞瘤或可能的视网膜色素上皮癌,1例为转移瘤。这4例的免疫闪烁显像均为阴性。与既定的诊断测试相结合,免疫闪烁显像可能在鉴别葡萄膜黑色素瘤与其他类似肿瘤方面发挥作用。